Related Experiment Video

Updated: Oct 3, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

E1A: tumor suppressor or oncogene? Preclinical and clinical investigations of E1A gene therapy

N T Ueno1, D Yu, M C Hung

  • 1Department of Molecualr and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 448, Houston, TX 77030, USA. nueno@mdanderson.org

Breast Cancer (Tokyo, Japan)
|January 16, 2002
PubMed

Insights

Adenovirus type 5 E1A gene therapy shows promise for breast and ovarian cancers. E1A suppresses tumors by reducing HER-2/neu overexpression, inducing apoptosis, and inhibiting metastasis.

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • The E1A gene was previously shown to downregulate HER-2/neu overexpression, reversing tumor and metastatic phenotypes.
  • E1A exhibits tumor suppressor functions, including inducing apoptosis and inhibiting metastasis.

Purpose of the Study:

  • To investigate the adenovirus type 5 E1A gene as a potential therapeutic agent for breast and ovarian cancers.
  • To recount the development of E1A as a therapeutic gene using a cationic liposome delivery system.

Main Methods:

  • Utilizing the adenovirus type 5 E1A gene.
  • Employing a cationic liposome gene delivery system.
  • Investigating therapeutic potential in breast and ovarian cancer models.

Main Results:

  • E1A gene downregulates HER-2/neu overexpression.
  • E1A reverses tumorigenic and metastatic phenotypes.
  • E1A functions as a tumor suppressor by inducing apoptosis and inhibiting metastasis.

Conclusions:

  • The adenovirus type 5 E1A gene holds significant potential as a therapeutic agent for breast and ovarian cancers.
  • The development of E1A as a therapeutic gene has been advanced through research at The University of Texas M. D. Anderson Cancer Center.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...